EV/EBITDA
-8.96
-0.14-1.59%
2 min ago
Summary
- As of February 26, 2025, ELVN EV/EBITDA is -8.96, with a fall of -0.14 (-1.59%) during the most recent trading day.
- Over the past year, ELVN EV/EBITDA has dropped by -1.73 (-23.93%).
- ELVN EV/EBITDA is now -135.79% below its all-time high of -3.80.
Performance
ELVN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ELVN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.6% | +1.5% | +1.3% |
| 1 m1 month | +7.3% | -7.4% | -6.7% |
| 3 m3 months | +17.6% | -17.7% | -16.2% |
| 6 m6 months | +11.6% | -9.2% | -11.0% |
| ytdytd | +10.2% | -10.3% | -9.3% |
| 1 y1 year | -23.9% | +48.8% | +20.0% |
| 5 y5 years | - | - | - |
ELVN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.6% | -10.18 | +12.0% | |
| 3 m | 3-month | -8.82 | -1.6% | -11.41 | +21.5% |
| 6 m | 6-month | -8.82 | -1.6% | -13.42 | +33.2% |
| 1 y | 1-year | -3.80 | -135.8% | -13.42 | +33.2% |
| 3 y | 3-year | -3.80 | -135.8% | -23.53 | +61.9% |
| 5 y | 5-year | -3.80 | -135.8% | -23.53 | +61.9% |
| alltime | all time | -3.80 | -135.8% | -23.53 | +61.9% |
Enliven Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -8.96(-10.2%) |
| Date | Value |
|---|---|
| 2024 | -9.98(+70.6%) |
| 2023 | -5.85 |
FAQ
- What is Enliven Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Enliven Therapeutics?
- What is ELVN EV/EBITDA year-to-date change?
- What is Enliven Therapeutics EV/EBITDA year-on-year change?
What is Enliven Therapeutics EV/EBITDA?
The current EV/EBITDA of ELVN is -8.96
What is the all time high EV/EBITDA for Enliven Therapeutics?
Enliven Therapeutics all-time high EV/EBITDA is -3.80
What is ELVN EV/EBITDA year-to-date change?
Enliven Therapeutics EV/EBITDA has changed by +1.02 (+10.22%) since the beginning of the year
What is Enliven Therapeutics EV/EBITDA year-on-year change?
Over the past year, ELVN EV/EBITDA has changed by -1.73 (-23.93%)